과제정보
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (grant number: NRF-2017M3A9A7050614). It was additionally supported by a grant from the National Research Foundation of Korea (NRF-2020M3A9I6A01036057).
참고문헌
- Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209-249 https://doi.org/10.3322/caac.21660
- Daly MC and Paquette IM (2019) Surveillance, epidemiology, and end results (SEER) and SEER-medicare databases: use in clinical research for improving colorectal cancer outcomes. Clin Colon Rect Surg 32, 61-68 https://doi.org/10.1055/s-0038-1673355
- Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS and Seo HG (2022) Prediction of cancer incidence and mortality in Korea, 2022. Cancer Res Treat 54, 345-351 https://doi.org/10.4143/crt.2022.179
- Dawson MA and Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27 https://doi.org/10.1016/j.cell.2012.06.013
- Portela A and Esteller M (2010) Epigenetic modifications and human disease. Nat Biotechnol 28, 1057-1068 https://doi.org/10.1038/nbt.1685
- Okugawa Y, Grady WM and Goel A (2015) Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology 149, 1204-1225.e12 https://doi.org/10.1053/j.gastro.2015.07.011
- Esteller M (2007) Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 Spec No 1, R50-R59 https://doi.org/10.1093/hmg/ddm018
- Feinberg AP and Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4, 143-153 https://doi.org/10.1038/nrc1279
- Toyota M, Ohe-Toyota M, Ahuja N and Issa JP (2000) Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci U S A 97, 710-715 https://doi.org/10.1073/pnas.97.2.710
- Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38, 787-793 https://doi.org/10.1038/ng1834
- Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA and Zali MR (2013) The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench 6, 120-128
- Ogino S, Nosho K, Kirkner GJ et al (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58, 90-96 https://doi.org/10.1136/gut.2008.155473
- Zlobec I, Bihl M, Foerster A, Rufle A and Lugli A (2011) Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. J Pathol 225, 336-343 https://doi.org/10.1002/path.2879
- Aryee MJ, Jaffe AE, Corrada-Bravo H et al (2014) Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363-1369 https://doi.org/10.1093/bioinformatics/btu049
- Johnson WE, Li C and Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 https://doi.org/10.1093/biostatistics/kxj037
- Joe S, Kim J, Lee JY et al (2023) Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea. BMB Rep 56, 563-568 https://doi.org/10.5483/BMBRep.2023-0096
- Lind GE, Danielsen SA, Ahlquist T et al (2011) Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer 10, 85
- Chang E, Park DI, Kim YJ et al (2010) Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepatogastroenterology 57, 720-727
- Kim MS, Louwagie J, Carvalho B et al (2009) Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 4, e6555
- Chen Z, Zhao G, Wang K et al (2021) Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection. J Cancer 12, 3678-3685 https://doi.org/10.7150/jca.57114
- Zou H, Harrington JJ, Shire AM et al (2007) Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 16, 2686-2696 https://doi.org/10.1158/1055-9965.EPI-07-0518
- Xiao W, Zhao H, Dong W et al (2015) Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer. Oncol Lett 9, 1383-1387 https://doi.org/10.3892/ol.2014.2815
- Zou H, Allawi H, Cao X et al (2012) Quantification of methylated markers with a multiplex methylation-specific technology. Clin Chem 58, 375-383 https://doi.org/10.1373/clinchem.2011.171264
- Muller D and Gyorffy B (2022) DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer 1877, 188722
- Matsusaka K, Funata S, Fukayama M and Kaneda A (2014) DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol 20, 3916-3926 https://doi.org/10.3748/wjg.v20.i14.3916
- Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 https://doi.org/10.1038/nature13480
- Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 https://doi.org/10.1016/j.ccr.2010.03.017
- Malta TM, de Souza CF, Sabedot TS et al (2018) Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro Oncol 20, 608-620 https://doi.org/10.1093/neuonc/nox183
- Herman JG, Umar A, Polyak K et al (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95, 6870-6875 https://doi.org/10.1073/pnas.95.12.6870
- Kim JH, Rhee YY, Bae JM et al (2013) Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status. Mod Pathol 26, 1013-1022 https://doi.org/10.1038/modpathol.2012.241
- Fu T, Liu Y, Li K et al (2016) Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients. Oncotarget 7, 86480-86489 https://doi.org/10.18632/oncotarget.13441
- Saadallah-Kallel A, Abdelmaksoud-Dammak R, Triki M et al (2017) Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer. Med Oncol 34, 147
- Wang Y, Long Y, Xu Y et al (2014) Prognostic and predictive value of CpG island methylator phenotype in patients with locally advanced nonmetastatic sporadic colorectal cancer. Gastroenterol Res Pract 2014, 436985
- Yagi K, Akagi K, Hayashi H et al (2010) Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16, 21-33 https://doi.org/10.1158/1078-0432.CCR-09-2006
- Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K and Nurkin SJ (2017) Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. Int J Surg 37, 42-49 https://doi.org/10.1016/j.ijsu.2016.08.528
- Kim SC, Kim J, Kim DW et al (2022) Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples. BMB Rep 55, 553-558 https://doi.org/10.5483/BMBRep.2022.55.11.110
- Lee B, Hwang S, Kim PG et al (2023) Introduction of the Korea BioData Station (K-BDS) for sharing biological data. Genomics Inform 21, e12